Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Which One Energizes You the Most These Tech Developments - 2Airbnb Unveils Airport Pickup Service Across 125 Cities in Global Expansion
- 3New dietary guidelines recommend more dairy, meat and fats: What to know
- 4South African army arrive in crime hotspots to help tackle gangs
- 5The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- Interpreter Starts Sobbing as 11-Year-Old Testifies About Last Time He Saw His Mom Before She Was Killed in Missile Strike
- The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- Fossils from China show complex life evolved millions of years earlier than once thought
- German politician urges more face-to-face interaction in digital age
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
- Experience Is standing by: 10 Pleasant Setting up camp Areas to
- World leaders, rights groups react to COP30 climate deal
- Figure out How to Adjust Work, Life, and an Internet based Degree
